SCHEMBL7166175

SCHEMBL7166175

C=CCc1cc(CC=C)c(O)c(-n2nc3ccc(Cl)cc3n2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MGAM O43451 3/20 0.36
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
MAPT P10636 4/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.33
TNKS O95271 1/20 0.32
PARP1 P09874 1/20 0.32
XDH P47989 1/20 0.31
GABRA1 P14867 4/20 0.31
GABRB2 P47870 4/20 0.31
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
GAA P10253 2/20 0.31
CNR1 P21554 2/20 0.31
CNR2 P34972 2/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724360 0.87 NPC1 (0.49) NPC1RAB9APTGDRPTGDR2MAPT
SCHEMBL712510 0.86 NPC1 (0.43) NPC1RAB9AMAPTKDM4ETNKS
SCHEMBL8069924 0.84 NPC1 (0.36) NPC1RAB9ARXFP1MAPTKDM4E
SCHEMBL1004621 0.84 TNKS (0.45) NPC1RAB9AMAPTKDM4ETNKS
SCHEMBL11668225 0.82 XDH (0.45) NPC1RAB9ARXFP1MAPTKDM4E
SCHEMBL9318971 0.80 NPC1 (0.39) NPC1RAB9AMGAMMAPTATM
SCHEMBL28360700 0.80 XDH (0.45) NPC1RAB9ARXFP1MAPTKDM4E
SCHEMBL7172273 0.80 ACE2 (0.33) NPC1RAB9AKDM4EGAAACE2
SCHEMBL9603768 0.80 NPC1 (0.42) NPC1RAB9AMAPTKDM4ETNKS
SCHEMBL17940508 0.79 NPC1 (0.41) NPC1RAB9ARXFP1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515051-B2 Stability and durability and a low loss rate when incorporated into automotive coatings; soluble in a variety of substrates including thermoplastic polymers and often are colorless CIBA SPECIALTY CHEMICALS CORPORATION 2003-02-04 US disclosed
US-6458872-B1 FOR USE IN AUTOMOTIVE COATINGS, THERMOPLASTIC FORMULATIONS CIBA SPECIALTY CHEMICALS CORPORATION 2002-10-01 US disclosed
US-20020099221-A1 Benzotriazole UV absorbers having enhanced durability RAVICHANDRAN RAMANATHAN (US) 2002-07-25 US disclosed
US-20020065341-A1 Benzotriazole UV absorbers having enhanced durability RAVICHANDRAN RAMANATHAN (US) 2002-05-30 US disclosed
US-6262151-B1 FOR AUTOMOTIVE COATINGS CIBA SPECIALTY CHEMICALS CORPORATION 2001-07-17 US disclosed
US-20010007886-A1 Benzotriazole UV absorbers having enhanced durability RAVICHANDRAN RAMANATHAN (US) 2001-07-12 US disclosed
US-6166218-A Benzotriazole UV absorbers having enhanced durability CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-12-26 US disclosed
US-5977219-A Benzotriazole UV absorbers having enhanced durability CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-11-02 US disclosed
US-4089839-A STABILIZERS/AGENTS UNIROYAL, INC. (US) 1978-05-16 US disclosed
US-3978074-A CATALYTIC HYDROGENATION UNIROYAL INC. (US) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099221-A1 Benzotriazole UV absorbers having enhanced durability TERT, AHR, ARNT NPC1 2921/4885RAB9A 4813/4885MGAM 2925/4885
US-20020065341-A1 Benzotriazole UV absorbers having enhanced durability TERT, AHR, ARNT NPC1 2921/4885RAB9A 4813/4885MGAM 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.